Kennedy Schaal is the CEO and Founder of Rejuve Biotech, where she leads efforts in applied genomic research and Artificial Intelligence at the forefront of longevity science. She is an accomplished biotechnology executive with a strong leadership track record in the field.

Schaal is recognized as a multi-published author on the science of longevity and applied genomics trials.